MX382156B - Sondas para formar imagenes de proteina de huntingtina. - Google Patents
Sondas para formar imagenes de proteina de huntingtina.Info
- Publication number
- MX382156B MX382156B MX2018002338A MX2018002338A MX382156B MX 382156 B MX382156 B MX 382156B MX 2018002338 A MX2018002338 A MX 2018002338A MX 2018002338 A MX2018002338 A MX 2018002338A MX 382156 B MX382156 B MX 382156B
- Authority
- MX
- Mexico
- Prior art keywords
- probes
- huntingtin protein
- imaging
- imaging huntingtin
- formula
- Prior art date
Links
- 102000016252 Huntingtin Human genes 0.000 title 1
- 108050004784 Huntingtin Proteins 0.000 title 1
- 238000003384 imaging method Methods 0.000 title 1
- 239000000523 sample Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012216 imaging agent Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nuclear Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562211118P | 2015-08-28 | 2015-08-28 | |
| PCT/US2016/049112 WO2017040336A1 (en) | 2015-08-28 | 2016-08-26 | Probes for imaging huntingtin protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018002338A MX2018002338A (es) | 2018-07-06 |
| MX382156B true MX382156B (es) | 2025-03-13 |
Family
ID=58103449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018002338A MX382156B (es) | 2015-08-28 | 2016-08-26 | Sondas para formar imagenes de proteina de huntingtina. |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US10137211B2 (enExample) |
| EP (1) | EP3340796B1 (enExample) |
| JP (1) | JP6944929B2 (enExample) |
| CN (1) | CN108135172B (enExample) |
| AU (1) | AU2016315648B2 (enExample) |
| BR (1) | BR112018003331B1 (enExample) |
| CA (1) | CA2995847C (enExample) |
| DK (1) | DK3340796T3 (enExample) |
| ES (1) | ES2885053T3 (enExample) |
| HR (1) | HRP20211156T1 (enExample) |
| HU (1) | HUE056509T2 (enExample) |
| IL (1) | IL257537B (enExample) |
| MX (1) | MX382156B (enExample) |
| PL (1) | PL3340796T3 (enExample) |
| PT (1) | PT3340796T (enExample) |
| RU (1) | RU2721419C2 (enExample) |
| SI (1) | SI3340796T1 (enExample) |
| WO (1) | WO2017040336A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20211778T1 (hr) | 2014-08-29 | 2022-03-18 | Chdi Foundation, Inc. | Kontrastna sredstva za slikovnu dijagnostiku huntingtin proteina |
| SG11201701578YA (en) | 2014-08-29 | 2017-03-30 | Chdi Foundation Inc | Probes for imaging huntingtin protein |
| SG11201701580XA (en) | 2014-08-29 | 2017-03-30 | Chdi Foundation Inc | Probes for imaging huntingtin protein |
| PL3197277T3 (pl) | 2014-08-29 | 2022-04-04 | Chdi Foundation, Inc. | Sondy do obrazowania molekularnego białka huntingtyny |
| CA2995847C (en) | 2015-08-28 | 2024-05-28 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
| WO2019157128A1 (en) | 2018-02-08 | 2019-08-15 | Phraxis Inc. | End to end anastomotic connector |
| EP3749225A4 (en) * | 2018-02-08 | 2021-11-17 | Phraxis Inc. | ONE-PIECE ANASTOMOTIC CONNECTOR |
| WO2020176424A1 (en) | 2019-02-25 | 2020-09-03 | Chdi Foundation, Inc. | Compounds for targeting mutant huntingtin protein and uses thereof |
| IL298941A (en) * | 2020-06-11 | 2023-02-01 | Chdi Foundation Inc | Heterocyclic compounds and imaging agents for the imaging of huntingtin protein |
| MX2023011888A (es) * | 2021-04-08 | 2023-12-06 | Chdi Foundation Inc | Compuestos de isoindolinona y agentes de formación de imágenes para la obtencion de imágenes de la proteína huntingtina. |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2126636T3 (es) | 1992-05-19 | 1999-04-01 | Adir | Derivados del bencimidazol con actividad antidiabetica y antiagregante plaquetaria. |
| JP2000351782A (ja) * | 1999-04-06 | 2000-12-19 | Yamanouchi Pharmaceut Co Ltd | メタボトロピックグルタメート受容体作用薬及び新規チアゾロベンゾイミダゾール誘導体 |
| AU2241400A (en) * | 1999-04-06 | 2000-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | Novel thiazolobenzoimidazole derivative |
| UY27003A1 (es) | 2000-11-06 | 2002-07-31 | Schering Ag | Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer |
| WO2005048953A2 (en) * | 2003-11-13 | 2005-06-02 | Ambit Biosciences Corporation | Amide derivatives as kinase modulators |
| TW201018678A (en) * | 2006-01-27 | 2010-05-16 | Astrazeneca Ab | Novel heteroaryl substituted benzothiazoles |
| FR2919610B1 (fr) * | 2007-08-02 | 2009-10-16 | Sanofi Aventis Sa | Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique |
| WO2010011964A2 (en) * | 2008-07-24 | 2010-01-28 | Siemens Medical Solutions Usa, Inc. | Imaging agents useful for identifying ad pathology |
| EP2218464A1 (en) * | 2009-02-11 | 2010-08-18 | Technische Universität München | Compounds for non-invasive measurement of aggregates of amyloid peptides |
| CN102438660A (zh) | 2009-03-23 | 2012-05-02 | 美国西门子医疗解决公司 | 用于检测神经障碍的显像剂 |
| HK1210732A1 (en) | 2012-07-11 | 2016-05-06 | Nimbus Iris, Inc. | Irak inhibitors and uses thereof |
| US9902702B2 (en) * | 2014-07-15 | 2018-02-27 | Bristol-Myers Squibb Company | Spirocycloheptanes as inhibitors of rock |
| PL3197277T3 (pl) | 2014-08-29 | 2022-04-04 | Chdi Foundation, Inc. | Sondy do obrazowania molekularnego białka huntingtyny |
| HRP20211778T1 (hr) | 2014-08-29 | 2022-03-18 | Chdi Foundation, Inc. | Kontrastna sredstva za slikovnu dijagnostiku huntingtin proteina |
| SG11201701580XA (en) | 2014-08-29 | 2017-03-30 | Chdi Foundation Inc | Probes for imaging huntingtin protein |
| SG11201701578YA (en) | 2014-08-29 | 2017-03-30 | Chdi Foundation Inc | Probes for imaging huntingtin protein |
| CA2995847C (en) | 2015-08-28 | 2024-05-28 | Chdi Foundation, Inc. | Probes for imaging huntingtin protein |
-
2016
- 2016-08-26 CA CA2995847A patent/CA2995847C/en active Active
- 2016-08-26 CN CN201680059497.1A patent/CN108135172B/zh active Active
- 2016-08-26 SI SI201631285T patent/SI3340796T1/sl unknown
- 2016-08-26 PL PL16842715T patent/PL3340796T3/pl unknown
- 2016-08-26 DK DK16842715.1T patent/DK3340796T3/da active
- 2016-08-26 ES ES16842715T patent/ES2885053T3/es active Active
- 2016-08-26 JP JP2018510377A patent/JP6944929B2/ja active Active
- 2016-08-26 MX MX2018002338A patent/MX382156B/es unknown
- 2016-08-26 HR HRP20211156TT patent/HRP20211156T1/hr unknown
- 2016-08-26 EP EP16842715.1A patent/EP3340796B1/en active Active
- 2016-08-26 AU AU2016315648A patent/AU2016315648B2/en active Active
- 2016-08-26 PT PT168427151T patent/PT3340796T/pt unknown
- 2016-08-26 HU HUE16842715A patent/HUE056509T2/hu unknown
- 2016-08-26 US US15/249,223 patent/US10137211B2/en active Active
- 2016-08-26 WO PCT/US2016/049112 patent/WO2017040336A1/en not_active Ceased
- 2016-08-26 RU RU2018110055A patent/RU2721419C2/ru active
- 2016-08-26 BR BR112018003331-6A patent/BR112018003331B1/pt active IP Right Grant
-
2018
- 2018-02-14 IL IL257537A patent/IL257537B/en active IP Right Grant
- 2018-10-26 US US16/172,425 patent/US10765764B2/en active Active
-
2020
- 2020-08-06 US US16/987,277 patent/US11344637B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017002703A (es) | Sondas para la proyección de imagen de la proteína huntingtina. | |
| IL282304A (en) | Topical pharmaceutical compositions | |
| IL270514B (en) | Agricultural compositions | |
| DOP2020000102A (es) | Compuestos útiles para inhibir a cdk7 | |
| MX2018002338A (es) | Sondas para formar imagenes de proteina de huntingtina. | |
| CY1123633T1 (el) | Ετεροκυκλικες ενωσεις και οι χρησεις αυτων | |
| MX2017002702A (es) | Sondas para la proyección de imagen de la proteína huntingtina. | |
| CL2017000654A1 (es) | Indazoles sustituidos con bencilo como inhibidores de bub1. | |
| CL2017003240A1 (es) | Anticuerpos anti-rnf43 novedosos y métodos para su uso | |
| MX383202B (es) | Sondas para la proyección de imagen de la proteína huntingtina. | |
| MX381487B (es) | Ciertos inhibidores de la proteina quinasa. | |
| EA201891024A1 (ru) | Соединения-ингибиторы tank-связывающей киназы | |
| GT201700185A (es) | Inhibidores selectivos de bace1 | |
| GEAP202114132A (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer | |
| BR112017004134A2 (pt) | ?sondas para imageamento de proteína de huntingtina? | |
| MX2017013875A (es) | Ciertos inhibidores de la proteína quinasa. | |
| HUE055762T2 (hu) | Nyújtott hatású készítmények | |
| IL271892B1 (en) | Stable cannabinoid compositions | |
| SV2019005838A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| MX2018013573A (es) | Ciertos inhibidores de la proteína cinasa. | |
| ITUB20160829A1 (it) | Fissativo per preparati istologici comprendente gliossale privo di acidi | |
| IL268708B (en) | Pharmaceutical compositions for combination therapy | |
| BR112018005299A2 (pt) | 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso | |
| AR100289A1 (es) | Formas de un inhibidor de pi3k | |
| UA40236S (uk) | Органайзер для дрібних деталей |